Company intelligence / Profile preview

Superhumans

Dubai, Dubai, United Arab Emirates

Ownership: Private
Development stage: Other

Overview

Superhuman is an investment platform and venture builder operating at the intersection of AI, biosciences, and human optimization. Backed by Terra-Invest, the company focuses on building and scaling ventures in longevity medicine, regenerative therapeutics, medical aesthetics, and performance optimization. Its ecosystem includes a network of clinics, consumer products, and digital platforms that utilize stem cells, exosomes, and AI-driven health protocols. Superhuman aims to make cutting-edge longevity technology personalized and accessible to a global audience.

Therapeutic areas: Other
Modalities: Cell therapyExosome-based therapySmall moleculePeptides
Industry: Investors

Beyond the preview

Go deeper on Superhumans.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Superhumans.

Explore the full profile